Abbott Laboratories (BCBA:ABT)

Market Cap	327.99T
Revenue (ttm)	51.37T
Net Income (ttm)	16.60T
Shares Out	n/a
EPS (ttm)	9,500.38
PE Ratio	19.76
Forward PE	24.42
Dividend	410.69 (0.79%)
Ex-Dividend Date	Jul 15, 2025

Volume	613
Average Volume	705
Open	52,175
Previous Close	52,050
Day's Range	49,080 - 52,525
52-Week Range	30,325 - 53,525
Beta	n/a
RSI	48.36
Earnings Date	Oct 15, 2025

About Abbott Laboratories

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism,...

• Industry: Electromedical and Electrotherapeutic Apparatus
• Founded: 1888
• Employees: 114,000
• Stock Exchange: Buenos Aires Stock Exchange
• Ticker Symbol: ABT

Financial Performance

In 2024, Abbott Laboratories's revenue was $41.95 billion, an increase of 4.59% compared to the previous year's $40.11 billion. Earnings were $13.35 billion, an increase of 134.19%.

Financial numbers in USD